Growing Questions Over Future of Alzheimer’s Research As More Clinical Trials Fail

Feb 3, 2019 | Alzheimer, Alzheimer's Disease Trial, CNS


New Atlas’ Rich Hardy writes the discontinuation of more major human clinical trials again raises doubts over whether the current hypothesis for Alzheimer’s disease is correct.  Roche/Genentech’s recent announcement to discontinue two major anti-Alzheimer’s clinical trials is further evidence of growing challenges.


Pin It on Pinterest